206 related articles for article (PubMed ID: 6761889)
1. Interpretation of pleural biopsy specimens and aspirates with the immunoperoxidase technique.
Herbert A; Gallagher PJ
Thorax; 1982 Nov; 37(11):822-7. PubMed ID: 6761889
[TBL] [Abstract][Full Text] [Related]
2. Pleural biopsy in the diagnosis of malignant mesothelioma.
Herbert A; Gallagher PJ
Thorax; 1982 Nov; 37(11):816-21. PubMed ID: 7163999
[TBL] [Abstract][Full Text] [Related]
3. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
4. The separation of benign and malignant mesothelial proliferations.
Churg A; Colby TV; Cagle P; Corson J; Gibbs AR; Gilks B; Grimes M; Hammar S; Roggli V; Travis WD
Am J Surg Pathol; 2000 Sep; 24(9):1183-200. PubMed ID: 10976692
[TBL] [Abstract][Full Text] [Related]
5. [Non-malignant cells in pleural fluid].
Zsiray M; Lukács J; Appel J; Lantos A; Szondy K
Orv Hetil; 1995 Jan; 136(1):27-30. PubMed ID: 7845663
[TBL] [Abstract][Full Text] [Related]
6. [Prospective comparison of the diagnostic value of cytology and immunocytology in pleural effusion studied by thoracoscopy and biopsy].
Neubauer A; Thalmann U; Musch R; Grosser H; Loddenkemper R; Huhn D
Klin Wochenschr; 1987 May; 65(9):400-6. PubMed ID: 3298829
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies.
Cagle PT; Churg A
Arch Pathol Lab Med; 2005 Nov; 129(11):1421-7. PubMed ID: 16253023
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3--a new tumor marker.
Kortsik CS; Werner P; Freudenberg N; Virchow JC; Kroegel C; Pott M; Matthys H
Lung; 1995; 173(2):79-87. PubMed ID: 7536281
[TBL] [Abstract][Full Text] [Related]
9. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.
Prakash UB; Reiman HM
Mayo Clin Proc; 1985 Mar; 60(3):158-64. PubMed ID: 3974296
[TBL] [Abstract][Full Text] [Related]
10. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
Cury PM; Butcher DN; Corrin B; Nicholson AG
J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens.
Maguire B; Whitaker D; Carrello S; Spagnolo D
Diagn Cytopathol; 1994; 10(2):130-4. PubMed ID: 8187591
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of alpha-1-antitrypsin and alpha-1-antichymotrypsin in fibrous histiocytomas using the immunoperoxidase technique.
du Boulay CE
Am J Surg Pathol; 1982 Sep; 6(6):559-64. PubMed ID: 6293323
[TBL] [Abstract][Full Text] [Related]
13. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
[TBL] [Abstract][Full Text] [Related]
14. p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections.
Mayall FG; Goddard H; Gibbs AR
J Pathol; 1992 Dec; 168(4):377-81. PubMed ID: 1484319
[TBL] [Abstract][Full Text] [Related]
15. Pathology of the pleura: what the pulmonologists need to know.
Cagle PT; Allen TC
Respirology; 2011 Apr; 16(3):430-8. PubMed ID: 21362105
[TBL] [Abstract][Full Text] [Related]
16. A new electrocautery pleural biopsy technique using an insulated-tip diathermic knife during semirigid pleuroscopy.
Sasada S; Kawahara K; Kusunoki Y; Okamoto N; Iwasaki T; Suzuki H; Kobayashi M; Hirashima T; Matsui K; Ohta M; Miyazawa T
Surg Endosc; 2009 Aug; 23(8):1901-7. PubMed ID: 19118434
[TBL] [Abstract][Full Text] [Related]
17. The distribution of lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin in normal hematopoietic cells and in myeloid leukemias: an immunoperoxidase study on cytocentrifuge preparations, smears, and paraffin sections.
Krugliak L; Meyer PR; Taylor CR
Am J Hematol; 1986 Jan; 21(1):99-109. PubMed ID: 3518416
[TBL] [Abstract][Full Text] [Related]
18. Lysozyme (muramidase) and alpha 1-anti-chymotrypsin as immunohistochemical tumour markers.
Nathrath WB; Meister P
Acta Histochem Suppl; 1982; 25():69-72. PubMed ID: 6283596
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cell cycle state may facilitate the histopathological diagnosis of malignant mesothelioma.
Sington JD; Morris LS; Nicholson AG; Coleman N
Histopathology; 2003 May; 42(5):498-502. PubMed ID: 12713628
[TBL] [Abstract][Full Text] [Related]
20. [Differential diagnosis of preneoplastic lesions of the pleura and of early mesothelioma: immunohistochemical and morphological findings].
Krismann M; Thattamparambil P; Simon F; Johnen G
Pathologe; 2006 Mar; 27(2):99-105. PubMed ID: 16435096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
